Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00929253 · ClinicalTrials.gov registry record · NA
Efficacy of Computer Delivered Community Reinforcement Approach (CRA) (Bup II)
A NA study, sponsored by Virginia Polytechnic Institute and State University.
- Completed
- Registry status
- NA
- Development phase
- 170
- Enrollment target
NCT00929253: Completed NA study, sponsored by Virginia Polytechnic Institute and State University.
NCT00929253 is a NA study that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 170 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00929253, a NA study, has completed, sponsored by Virginia Polytechnic Institute and State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 170 participants
- Enrollment target
Study Summary
This study is designed to examine the effects of combined buprenorphine and voucher incentives to promote abstinence from illicit opiate use, along with or without computer-delivered therapy, during treatment of opioid dependence.
Primary Outcome
Abstinence defined as the longest documented period of continuous abstinence from opioids and cocaine
Interventions
- BEHAVIORAL Therapy
- BEHAVIORAL CM
- DRUG Suboxone
- BEHAVIORAL CRA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2007-09 |
| Est. Completion | 2010-04 |
| Phase | NA |
What the finished NCT00929253 record still lists
NCT00929253 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 4 interventions - of which Therapy is the first listed.
NCT00929253 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00929253 about?
NCT00929253 is a clinical study titled "Efficacy of Computer Delivered Community Reinforcement Approach (CRA) (Bup II)". This study is designed to examine the effects of combined buprenorphine and voucher incentives to promote abstinence from illicit opiate use, along with or without computer-delivered therapy, during treatment of opioid dependence.
What is the current status of trial NCT00929253?
This trial is currently completed. It is a NA study. The enrollment target is 170 participants. The study started on 2007-09. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00929253?
The interventions under investigation include: Therapy (BEHAVIORAL), CM (BEHAVIORAL), Suboxone (DRUG), CRA (BEHAVIORAL).
Who is sponsoring clinical trial NCT00929253?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00929253's enrollment target sits among peer trials
170 614th of 2000 higher than 1,382 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia